Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05268744 · ClinicalTrials.gov registry record · Phase 2
Micronutrient Supplementation in Children With ASD
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT05268744 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants.
The verdict
NCT05268744, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
An open-label examination of changes in metabolites with use of micronutrients in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures monthly at school with teachers and parents report.
Interventions
- DRUG Micronutrient
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2023-01-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05268744
The ClinicalTrials.gov registry entry for NCT05268744 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micronutrient is the first listed.
NCT05268744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05268744 about?
NCT05268744 is a clinical study titled "Micronutrient Supplementation in Children With ASD". An open-label examination of changes in metabolites with use of micronutrients in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures monthly at school with teachers and parents report.
What is the current status of trial NCT05268744?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2022-11-14. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT05268744?
The interventions under investigation include: Micronutrient (DRUG).
Who is sponsoring clinical trial NCT05268744?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.